FDA 483 - St. Theresa's General Hospital - June 08, 2012

An FDA inspection of St. Theresa's General Hospital, a clinical facility in Hyderabad, India, identified significant deviations from study protocols during a bioequivalence study. Observations included failures to adhere to subject inclusion/exclusion criteria and improper blood sampling procedures. These findings indicate a lack of adherence to established research protocols.